
Oramed Pharmaceuticals Inc. (ORMP)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
4.0300 - Open
4.0300 - Bid 2.8800 x 200
- Ask 4.9600 x 200
- Day's Range
3.8300 - 4.0300 - 52 Week Range
1.9800 - 4.2200 - Volume
109,018 - Avg. Volume
140,168 - Market Cap (intraday)
155.92M - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
2.57 - EPS (TTM)
1.5000 - Earnings Date (est.) May 15, 2026
- Forward Dividend & Yield 0.25 (6.20%)
- Ex-Dividend Date Jan 16, 2026
- 1y Target Est
6.25
Recent News: ORMP
View MorePerformance Overview: ORMP
Trailing total returns as of 4/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends: ORMP
View MoreAnalyst Insights: ORMP
View MoreStatistics: ORMP
View MoreValuation Measures
-
Market Cap
163.00M
-
Enterprise Value
37.93M
-
Trailing P/E
2.69
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
85.47
-
Price/Book (mrq)
0.82
-
Enterprise Value/Revenue
18.96
-
Enterprise Value/EBITDA
0.50
Financial Highlights
Profitability and Income Statement
-
Profit Margin
3,202.50%
-
Return on Assets (ttm)
-4.88%
-
Return on Equity (ttm)
37.10%
-
Revenue (ttm)
2M
-
Net Income Avi to Common (ttm)
63.24M
-
Diluted EPS (ttm)
1.5000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
125.89M
-
Total Debt/Equity (mrq)
0.41%
-
Levered Free Cash Flow (ttm)
3.92M
Compare To: ORMP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.





